Fludarabine phosphate

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2269 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Leukemia	D007938	—	C95	398	538	99	16	58	938
Lymphoma	D008223	—	C85.9	272	308	36	2	38	563
Myeloid leukemia acute	D015470	—	C92.0	175	243	57	6	26	436
Myeloid leukemia	D007951	—	C92	162	238	46	5	24	405
Lymphoid leukemia	D007945	—	C91	176	213	43	7	20	390
Myelodysplastic syndromes	D009190	—	D46	123	256	25	2	29	382
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	172	187	20	5	23	345
B-cell chronic lymphocytic leukemia	D015451	—	C91.1	117	178	36	3	15	303
Non-hodgkin lymphoma	D008228	—	C85.9	153	160	16	1	21	293
Preleukemia	D011289	—	—	91	178	14	2	19	266

Show 11 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Neoplasms	D009369	—	C80	185	143	5	—	16	294
B-cell lymphoma	D016393	—	—	131	79	5	—	11	192
Hematologic neoplasms	D019337	—	—	78	116	3	—	19	185
Plasma cell neoplasms	D054219	—	—	92	76	9	—	15	172
Bcr-abl positive chronic myelogenous leukemia	D015464	EFO_0000340	—	31	108	7	—	11	139
Hodgkin disease	D006689	—	C81	44	80	3	—	13	122
Melanoma	D008545	—	—	54	63	2	—	2	103
Large b-cell lymphoma diffuse	D016403	—	C83.3	58	49	4	—	5	100
Follicular lymphoma	D008224	—	C82	38	55	12	—	5	99
Mantle-cell lymphoma	D020522	—	C83.1	41	53	9	—	6	93

Show 49 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Carcinoma	D002277	—	C80.0	58	26	—	—	4	71
Ovarian neoplasms	D010051	EFO_0003893	C56	45	22	—	—	—	55
T-cell lymphoma	D016399	—	—	25	32	—	—	5	55
Plasmacytoma	D010954	—	C90.3	14	30	—	—	9	49
Breast neoplasms	D001943	EFO_0003869	C50	34	25	—	—	—	46
Renal cell carcinoma	D002292	EFO_0000376	—	28	22	—	—	3	42
Hematologic diseases	D006402	EFO_0005803	D75.9	10	21	—	—	9	37
Precursor t-cell lymphoblastic leukemia-lymphoma	D054218	—	—	34	15	—	—	—	37
Non-small-cell lung carcinoma	D002289	—	—	28	15	—	—	—	35
T-cell lymphoma peripheral	D016411	—	—	17	20	—	—	4	35

Show 272 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Rhabdoid tumor	D018335	—	—	4	—	—	—	—	4
Female genital neoplasms	D005833	—	—	4	—	—	—	—	4
Small cell lung carcinoma	D055752	—	—	3	—	—	—	—	3
Wilms tumor	D009396	EFO_0000212	—	3	—	—	—	—	3
Nervous system diseases	D009422	—	G00-G99	3	—	—	—	—	3
Autoimmune diseases of the nervous system	D020274	—	—	3	—	—	—	—	3
Ependymoma	D004806	—	—	2	—	—	—	—	2
Gastrointestinal stromal tumors	D046152	EFO_0000505	C49.A	2	—	—	—	—	2
Adrenocortical carcinoma	D018268	—	—	2	—	—	—	—	2
Aids-related lymphoma	D016483	EFO_1001365	—	1	—	—	—	1	2

Show 55 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Abnormal karyotype	D059786	—	—	—	—	—	—	1	1
Hemoglobin c disease	D006445	—	D58.2	—	—	—	—	1	1
Type 1 hyper-igm immunodeficiency syndrome	D053307	—	—	—	—	—	—	1	1
Hereditary congenital and neonatal diseases and abnormalities	D009358	—	—	—	—	—	—	1	1
Primary graft dysfunction	D055031	—	—	—	—	—	—	1	1
Antiphospholipid syndrome	D016736	EFO_0002689	D68.61	—	—	—	—	1	1
Alveolar soft part sarcoma	D018234	—	—	—	—	—	—	1	1